[시장보고서]플라스미드 정제 시장 규모, 점유율, 동향 분석 보고서 : 제품 및 서비스별, 등급별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

플라스미드 정제 시장 규모, 점유율, 동향 분석 보고서 : 제품 및 서비스별, 등급별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Plasmid Purification Market Size, Share & Trends Analysis Report By Product & Service, By Grade, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033

상품코드 : 1790196

리서치사 : Grand View Research

발행일 : 2025년 07월

페이지 정보 : 영문 120 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,950

￦ 8,590,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950

￦ 10,034,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950

￦ 12,922,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

플라스미드 정제 시장 개요

세계 플라스미드 정제 시장 규모는 2024년 19억 1,000만 달러로 평가되었습니다. 2033년에는 52억 8,000만 달러에 달하고, 2025-2033년 12.09%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 재조합 DNA 기술 제품에 대한 수요 증가와 플라스미드 정제의 기술 발전은 시장 성장을 가속하는 요인 중 일부입니다.

또한, 만성질환 치료에 대한 세포 및 유전자 치료의 수용이 증가하고 있는 것도 시장 성장을 더욱 촉진하고 있습니다.

지역별 시장 점유율 분석, 2024년과 2033년
지역별 시장 대시보드
시장 규모, 예측 동향 분석, 2021-2033년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 스웨덴
- 덴마크
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제9장 경쟁 구도

기업/경쟁 분류
전략 매핑
기업 시장 현황 분석, 2024년
기업 개요/상장기업
- Merck KGaA
- QIAGEN
- Thermo Fisher Scientific, Inc.
- Takara Bio
- Promega Corporation
- Zymo Research
- MP BIOMEDICALS
- New England Biolabs
- MCLAB
- Applied Biological Materials, Inc.

LSH

영문 목차

영문목차

Plasmid Purification Market Summary

The global plasmid purification market size was estimated at USD 1.91 billion in 2024 and is projected to reach USD 5.28 billion by 2033, growing at a CAGR of 12.09% from 2025 to 2033. The growing demand for recombinant DNA technology products and technological advancements in plasmid purification are some of the factors driving market growth.

Moreover, the rising acceptance of cell and gene therapy to treat chronic diseases further propels market growth.

Global Plasmid Purification Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global plasmid purification market report based on product & service, grade, application, end-use, and region.

Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
Products
- Instruments
- Kits & Reagents
Services
Grade Outlook (Revenue, USD Million, 2021 - 2033)
Molecular Grade
Transfection Grade
Application Outlook (Revenue, USD Million, 2021 - 2033)
Cloning & Protein Expression
Transfection & Gene Editing
Others
End-use Outlook (Revenue, USD Million, 2021 - 2033)
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
Latin America
- Brazil
- Argentina
MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definitions
- 1.2.1. Product & Service Segment
- 1.2.2. Grade Segment
- 1.2.3. Application Segment
- 1.2.4. End Use Segment
1.3. Information Analysis
- 1.3.1. Market formulation & data visualization
1.4. Data Validation & Publishing
1.5. Information Procurement
- 1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape

Chapter 3. Plasmid Purification Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Growing demand for recombinant DNA technology (rDNA) products
  - 3.2.1.2. Technological advancements in plasmid purification
  - 3.2.1.3. Increasing adoption of cell and gene therapies
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Ethical constraints related to the use of rDNA technology
3.3. Plasmid Purification Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. Plasmid Purification Market: Product & Service Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Plasmid Purification Market Product & Service Movement Analysis
4.3. Global Plasmid Purification Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
4.4. Products
- 4.4.1. Products market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.2. Instruments
  - 4.4.2.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.3. Kits & Reagents
  - 4.4.3.1. Kits & reagents market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Services
- 4.5.1. Services market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Plasmid Purification Market: Grade Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Plasmid Purification Market Grade Movement Analysis
5.3. Global Plasmid Purification Market Size & Trend Analysis, by Grade, 2021 to 2033 (USD Million)
5.4. Molecular Grade
- 5.4.1. Molecular-grade market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Transfection Grade
- 5.5.1. Transfection grade market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Plasmid Purification Market: Application Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Plasmid Purification Market Application Movement Analysis
6.3. Global Plasmid Purification Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Cloning & Protein Expression
- 6.4.1. Cloning & protein expression market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Transfection & Gene Editing
- 6.5.1. Transfection & gene editing market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Others
- 6.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Plasmid Purification Market: End Use Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Global Plasmid Purification Market End Use Movement Analysis
7.3. Global Plasmid Purification Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
- 7.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Academic & Research Institutes
- 7.5.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Contract Research Organizations
- 7.6.1. Contract research organizations market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Plasmid Purification Market: Regional Estimates & Trend Analysis

8.1. Regional Market Share Analysis, 2024 & 2033
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
8.4. North America
- 8.4.1. U.S.
  - 8.4.1.1. Key country dynamics
  - 8.4.1.2. Competitive scenario
  - 8.4.1.3. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.2. Canada
  - 8.4.2.1. Key country dynamics
  - 8.4.2.2. Competitive scenario
  - 8.4.2.3. Canada market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.3. Mexico
  - 8.4.3.1. Key country dynamics
  - 8.4.3.2. Competitive scenario
  - 8.4.3.3. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
8.5. Europe
- 8.5.1. UK
  - 8.5.1.1. Key country dynamics
  - 8.5.1.2. Competitive scenario
  - 8.5.1.3. UK market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.2. Germany
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. Competitive scenario
  - 8.5.2.3. Germany market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.3. France
  - 8.5.3.1. Key country dynamics
  - 8.5.3.2. Competitive scenario
  - 8.5.3.3. France market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.4. Italy
  - 8.5.4.1. Key country dynamics
  - 8.5.4.2. Competitive scenario
  - 8.5.4.3. Italy market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.5. Spain
  - 8.5.5.1. Key country dynamics
  - 8.5.5.2. Competitive scenario
  - 8.5.5.3. Spain market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.6. Norway
  - 8.5.6.1. Key country dynamics
  - 8.5.6.2. Competitive scenario
  - 8.5.6.3. Norway market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.7. Sweden
  - 8.5.7.1. Key country dynamics
  - 8.5.7.2. Competitive scenario
  - 8.5.7.3. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.8. Denmark
  - 8.5.8.1. Key country dynamics
  - 8.5.8.2. Competitive scenario
  - 8.5.8.3. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
8.6. Asia Pacific
- 8.6.1. Japan
  - 8.6.1.1. Key country dynamics
  - 8.6.1.2. Competitive scenario
  - 8.6.1.3. Japan market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.2. China
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Competitive scenario
  - 8.6.2.3. China market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.3. India
  - 8.6.3.1. Key country dynamics
  - 8.6.3.2. Competitive scenario
  - 8.6.3.3. India market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.4. Australia
  - 8.6.4.1. Key country dynamics
  - 8.6.4.2. Competitive scenario
  - 8.6.4.3. Australia market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.5. South Korea
  - 8.6.5.1. Key country dynamics
  - 8.6.5.2. Competitive scenario
  - 8.6.5.3. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.6. Thailand
  - 8.6.6.1. Key country dynamics
  - 8.6.6.2. Competitive scenario
  - 8.6.6.3. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
8.7. Latin America
- 8.7.1. Brazil
  - 8.7.1.1. Key country dynamics
  - 8.7.1.2. Competitive scenario
  - 8.7.1.3. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.2. Argentina
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Competitive scenario
  - 8.7.2.3. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
8.8. MEA
- 8.8.1. South Africa
  - 8.8.1.1. Key country dynamics
  - 8.8.1.2. Competitive scenario
  - 8.8.1.3. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.2. Saudi Arabia
  - 8.8.2.1. Key country dynamics
  - 8.8.2.2. Competitive scenario
  - 8.8.2.3. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.3. UAE
  - 8.8.3.1. Key country dynamics
  - 8.8.3.2. Competitive scenario
  - 8.8.3.3. UAE market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.4. Kuwait
  - 8.8.4.1. Key country dynamics
  - 8.8.4.2. Competitive scenario
  - 8.8.4.3. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
- 9.4.1. Merck KGaA
  - 9.4.1.1. Company overview
  - 9.4.1.2. Financial performance
  - 9.4.1.3. Product/Service benchmarking
  - 9.4.1.4. Strategic initiatives
- 9.4.2. QIAGEN
  - 9.4.2.1. Company overview
  - 9.4.2.2. Financial performance
  - 9.4.2.3. Product/Service benchmarking
  - 9.4.2.4. Strategic initiatives
- 9.4.3. Thermo Fisher Scientific, Inc.
  - 9.4.3.1. Company overview
  - 9.4.3.2. Financial performance
  - 9.4.3.3. Product/Service benchmarking
  - 9.4.3.4. Strategic initiatives
- 9.4.4. Takara Bio
  - 9.4.4.1. Company overview
  - 9.4.4.2. Financial performance
  - 9.4.4.3. Product/Service benchmarking
  - 9.4.4.4. Strategic initiatives
- 9.4.5. Promega Corporation
  - 9.4.5.1. Company overview
  - 9.4.5.2. Financial performance
  - 9.4.5.3. Product/Service benchmarking
  - 9.4.5.4. Strategic initiatives
- 9.4.6. Zymo Research
  - 9.4.6.1. Company overview
  - 9.4.6.2. Financial performance
  - 9.4.6.3. Product/Service benchmarking
  - 9.4.6.4. Strategic initiatives
- 9.4.7. MP BIOMEDICALS
  - 9.4.7.1. Company overview
  - 9.4.7.2. Financial performance
  - 9.4.7.3. Product/Service benchmarking
  - 9.4.7.4. Strategic initiatives
- 9.4.8. New England Biolabs
  - 9.4.8.1. Company overview
  - 9.4.8.2. Financial performance
  - 9.4.8.3. Product/Service benchmarking
  - 9.4.8.4. Strategic initiatives
- 9.4.9. MCLAB
  - 9.4.9.1. Company overview
  - 9.4.9.2. Financial performance
  - 9.4.9.3. Product/Service benchmarking
  - 9.4.9.4. Strategic initiatives
- 9.4.10. Applied Biological Materials, Inc.
  - 9.4.10.1. Company overview
  - 9.4.10.2. Financial performance
  - 9.4.10.3. Product/Service benchmarking
  - 9.4.10.4. Strategic initiatives

한글목차

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 플라스미드 정제 시장 변수, 동향, 범위

제4장 플라스미드 정제 시장 : 제품 및 서비스별, 추정·동향 분석

제5장 플라스미드 정제 시장 : 등급별, 추정·동향 분석

제6장 플라스미드 정제 시장 : 용도별, 추정·동향 분석

제7장 플라스미드 정제 시장 : 최종 용도별, 추정·동향 분석

제8장 플라스미드 정제 시장 : 지역별, 추정·동향 분석